Introduction to Animal Models of Femoral Head Necrosis

Animal models of osteonecrosis of the femoral head (ONFH) serve as a critical in vivo platform for investigating its pathogenesis and evaluating hip-preserving drugs and biomaterials. These models typically employ rabbits, rats, or large bipedal animals, with disease induction achieved through methods such as hormone administration—e.g., high-dose methylprednisolone to induce microcirculatory dysfunction—cryotherapy using liquid nitrogen, or vascular ligation, including physical occlusion of the medial and lateral circumflex femoral arteries. Such models effectively recapitulate the hallmark pathological processes observed in human ONFH, including microvascular thrombosis, adipogenic differentiation of bone marrow stromal cells, widespread apoptosis of osteocytes, and, in later stages, trabecular fracture and collapse. Consequently, they provide robust in vivo pharmacological validation for the development of novel therapeutics aimed at improving bone blood supply, promoting bone regeneration, and inhibiting bone resorption.

Advantages of the Aniphe BioLablogical Animal Model Platform for Femoral Head Necrosis

The Aniphe BioLablogical Osteonecrosis of the Femoral Head (ONFH) animal model platform is dedicated to research in orthopedic diseases and regenerative medicine, offering clients standardized, one-stop research services.

	The model system has been refined. It supports multiple femoral head necrosis modeling approaches, including hormone-induced models, LPS‑induced models combined with hormones, and vascular occlusion–based models.
	Well-established modeling expertise The modeling procedure is standardized, the necrotic phenotype is stable, and the model exhibits excellent reproducibility and consistency.
	Comprehensive evaluation system It encompasses multidimensional assessments, including imaging (micro-CT, MRI), histopathology, and bone metabolism markers.
	The testing platform is fully equipped. It is capable of performing HE staining, Masson’s trichrome staining, TRAP staining, IHC, and bone morphological analysis, among other assays.
	Customization Service Capability The modeling cycle, dosing regimen, and endpoint evaluation criteria can be tailored to the research objectives.

Modeling cycle	2–12 weeks
Laboratory animals	SD rats, New Zealand rabbits, etc.
Positive drug	Bisphosphonates, statins (such as simvastatin), anticoagulants (e.g., enoxaparin), and traditional Chinese medicines that promote blood circulation and resolve blood stasis (e.g., Compound Danshen Tablets), among others.
Application areas	Investigate the mechanisms underlying hormone‑induced vascular endothelial injury, dysregulation of lipid metabolism, and osteocyte apoptosis, as well as evaluate the efficacy of preventive pharmacological agents and early intervention strategies.

Construction of an Animal Model of Femoral Head Necrosis

Hormone‑induced femoral head necrosis animal models are among the most widely used experimental systems for studying this condition, primarily to replicate corticosteroid‑related femoral head necrosis observed in clinical practice. These models typically employ high doses of glucocorticoids—such as methylprednisolone or dexamethasone—administered either continuously or intermittently. By inducing disturbances in intraosseous lipid metabolism, hypertrophy of bone marrow adipocytes, microcirculatory impairment, and osteocyte apoptosis, these protocols progressively lead to ischemic necrosis of the femoral head. Some studies further incorporate lipopolysaccharide (LPS) pretreatment to enhance modeling success and increase the incidence of necrosis. In these models, animals exhibit characteristic pathological changes, including trabecular fracture, an increased number of empty lacunae in osteocytes, and structural disruption of the femoral head, making them well suited for investigating the pathogenic mechanisms of femoral head necrosis and for evaluating the efficacy of pharmacological, stem cell–based, and tissue engineering–derived therapeutic strategies.